Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Intended Use
This schedule allows your body time to adjust to the infusions while you and your provider can track your response and watch for any potential side effects
Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) treatment of patients with Richters syndrome (RS), refractory prolymphocytic leukemia (PLL) or refractory non-Hodgkins lymphoma (NHL)
At the time of this writing, no serious side effects have been linked to the topical use of copper peptides
Your prescriber will provide guidance on how it should be used
US$ 29.02
US$ 25.15
US$ 22.57
US$ 26.63
US$ 29.31
